CLINUVEL PHARMACEUTICALS said its American Depositary Shares, or ADSs, are expected to begin trading on Nasdaq, marking a new step for the Australia-based company in the U.S. market. The shares are set to trade under the ticker CUVL.
According to the announcement, the listing is planned for Nasdaq’s Global Select Market, the exchange’s top tier. That places CLINUVEL among companies meeting the standards required for admission to one of Nasdaq’s highest-profile market segments.
The move gives U.S. investors a clearer route to trade CLINUVEL through ADSs rather than buying shares in its home market. For international companies, an ADS structure can broaden visibility and make trading more accessible for investors in the United States.
CLINUVEL disclosed the expected start of trading in a statement issued from Melbourne and New York. The company’s Nasdaq debut is positioned as an important milestone as it expands its presence on a major U.S. exchange.
